ShockWave Medical, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 4 | $0.99 | $0.99 | $0.99 |
| Q2 2024 | 4 | $1.11 | $1.43 | $1.17 |
| Q3 2024 | 1 | $1.29 | $1.29 | $1.29 |
| Q4 2024 | 1 | $1.51 | $1.51 | $1.51 |
| Q1 2025 | 2 | $1.42 | $1.42 | $1.42 |
| Q2 2025 | 2 | $1.55 | $1.55 | $1.55 |
| Q3 2025 | 2 | $1.61 | $1.61 | $1.61 |
| Q4 2025 | 2 | $1.78 | $1.78 | $1.78 |
| Q1 2026 | 1 | $1.60 | $1.60 | $1.60 |
| Q2 2026 | 1 | $1.78 | $1.78 | $1.78 |
| Q3 2026 | 1 | $1.86 | $1.86 | $1.86 |
| Q4 2026 | 1 | $2.07 | $2.07 | $2.07 |
ShockWave Medical, Inc. Earnings Date And Information
ShockWave Medical, Inc. last posted its earnings results on Monday, May 6th, 2024. The company reported $1.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.98 by $0.46. The company had revenue of 218.81 M for the quarter and had revenue of 730.23 M for the year. ShockWave Medical, Inc. has generated $4 earnings per share over the last year ($3.85 diluted earnings per share) and currently has a price-to-earnings ratio of 76.34. ShockWave Medical, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based on prior year's report dates.
ShockWave Medical, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/06/2024 | Q1 2024 | $0.98 | $1.48 | 0.5 | $207.67 M | $218.81 M |
| 02/26/2024 | Q4 2023 | $1.20 | $199.43 M | $202.98 M | ||
| 11/06/2023 | Q3 2023 | $0.79 | $0.95 | 0.16 | $186.02 M | |
| 08/07/2023 | Q2 2023 | $0.86 | $0.79 | -0.07 | $180.17 M | |
| 05/08/2023 | Q1 2023 | $0.81 | $1.07 | 0.26 | $147.30 M | $161.07 M |
| 02/27/2023 | Q4 2022 | $3.89 | $143.18 M | $144.03 M | ||
| 11/07/2022 | Q3 2022 | $0.67 | $0.92 | 0.25 | $131.33 M | |
| 08/08/2022 | Q2 2022 | $0.44 | $0.71 | 0.27 | $120.75 M | |
| 05/09/2022 | Q1 2022 | $0.18 | $0.39 | 0.21 | $86.41 M | $93.63 M |
| 02/25/2022 | Q4 2021 | $0.37 | $75.43 M | $84.18 M | ||
| 11/08/2021 | Q3 2021 | -$0.06 | $0.06 | 0.12 | $65.16 M | |
| 08/09/2021 | Q2 2021 | -$0.41 | -$0.01 | 0.4 | $55.91 M | |
| 05/10/2021 | Q1 2021 | -$0.42 | -$0.68 | -0.26 | $29.90 M | $31.90 M |
| 02/26/2021 | Q4 2020 | -$0.46 | $20.16 M | $22.72 M | ||
| 11/10/2020 | Q3 2020 | -$0.38 | $19.59 M | |||
| 08/12/2020 | Q2 2020 | -$0.56 | $10.29 M | |||
| 05/13/2020 | Q1 2020 | -$0.59 | $14.17 M | $15.20 M | ||
| 03/12/2020 | Q4 2019 | -$0.49 | $13.47 M | $14.31 M | ||
| 11/08/2019 | Q3 2019 | -$0.46 | $11.33 M | |||
| 08/06/2019 | Q2 2019 | -$0.38 | $10.01 M |
ShockWave Medical, Inc. Earnings: Frequently Asked Questions
-
When is ShockWave Medical, Inc.'s earnings date?
ShockWave Medical, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off last year's report dates.
-
Did ShockWave Medical, Inc. beat their earnings estimates last quarter?
In the previous quarter, ShockWave Medical, Inc. (:SWAV) reported $1.44 earnings per share (EPS) to beat the analysts' consensus estimate of $0.98 by $0.46.
-
How can I listen to ShockWave Medical, Inc.'s earnings conference call?
The conference call for ShockWave Medical, Inc.'s latest earnings report can be listened to online.
-
How can I read ShockWave Medical, Inc.'s conference call transcript?
The conference call transcript for ShockWave Medical, Inc.'s latest earnings report can be read online.
-
How much revenue does ShockWave Medical, Inc. generate each year?
ShockWave Medical, Inc. (:SWAV) has a recorded annual revenue of $730.23 M.
-
How much profit does ShockWave Medical, Inc. generate each year?
ShockWave Medical, Inc. (:SWAV) has a recorded net income of $730.23 M. ShockWave Medical, Inc. has generated $4.01 earnings per share over the last four quarters.
-
What is ShockWave Medical, Inc.'s price-to-earnings ratio?
ShockWave Medical, Inc. (:SWAV) has a price-to-earnings ratio of 76.34 and price/earnings-to-growth ratio is 7.47.
